Targeting the sodium-dependent multivitamin transporter (SMVT) for improving the oral absorption properties of a retro-inverso Tat nonapeptide

Pharmaceutical Research

Volumn 18, Issue 7, 2001, Pages 950-956

  Ramanathan, S ^a   Pooyan, S ^b   Stein, S ^a,b,c   Prasad, P D ^d   Wang, J ^a,b   Leibowitz, M J ^c,e   Ganapathy, V ^d   Sinko, P J ^a,e,f  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^d MEDICAL COLLEGE OF GEORGIA   (United States)

^e RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^f New Jersey Center for Biomaterials   (United States)

Author keywords

Biotin; Caco 2; CHO; Oral absorption; Tat peptide; Vitamin transporter

Indexed keywords

BIOCYTIN; BIOTIN; BIOTIN DERIVATIVE; CARRIER PROTEIN; MULTIVITAMIN; N ACETYL DEXTRO LYSYL DEXTRO ARGINYL DEXTRO ARGINYL DEXTRO ARGINYL DEXTRO GLUTAMINYL DEXTRO ARGINYL DEXTRO ARGINYL DEXTRO LYSYL DEXTRO LYSYL DEXTRO ARGININE; N ACETYL DEXTRO LYSYL:(EPSILON BIOTIN) DEXTRO ARGINYL DEXTRO ARGINYL DEXTRO ARGINYL DEXTRO GLUTAMINYL DEXTRO ARGINYL DEXTRO ARGINYL DEXTRO LYSYL DEXTRO LYSYL DEXTRO ARGININE; NONAPEPTIDE; RETRO INVERSO TAT NONAPEPTIDE; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL STRAIN CACO 2; CHO CELL; COMPETITIVE INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; INTESTINE ABSORPTION; NONHUMAN; ORAL DRUG ADMINISTRATION; PASSIVE TRANSPORT; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEIN STRUCTURE; PROTEIN TARGETING; PROTEIN TRANSPORT; TEMPERATURE DEPENDENCE; TRANSPORT KINETICS;

ADMINISTRATION, ORAL; ANIMALS; ANTI-HIV AGENTS; BIOLOGICAL TRANSPORT, ACTIVE; BIOTIN; CACO-2 CELLS; CARRIER PROTEINS; CHO CELLS; CRICETINAE; DRUG DELIVERY SYSTEMS; GENE PRODUCTS, TAT; HUMANS; INTESTINAL ABSORPTION; MEMBRANE GLYCOPROTEINS; SYMPORTERS;

EID: 0034868135     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1010932126662     Document Type: Article

References (32)

1. Direct evidence for a peptide transporter (PepT1)-mediated uptake of a nonpeptide prodrug valacyclovir
2. Mapping the binding site of the small intestinal peptide carrier (PepT1) using comparative molecular field analysis
3. Electrophysiological characteristics of the proton-coupled peptide transporter PEPT 2 cloned from rat brain
4. Characterization of the oral absorption of beta-lactam antibiotics. II. Competitive absorption and peptide carrier specificity
5. Optimizing oral absorption of peptides using prodrug strategies
6. Oral absorption of peptides: Influence of pH and inhibitors on the intestinal hydrolysis of leu-enkephalin and analogues
7. Effects of polyacrylic polymers on the luminal proteolysis of peptide drugs in the colon
8. Effects of polyacrylic polymers on the degradation of insulin and peptide drugs by chymotrypsin and trypsin
9. Impact of regional intestinal pH modulation on absorption of peptide drugs: Oral absorption studies of salmon calcitonin in beagle dogs
10. Biopharmaceutical approaches for developing and assessing oral peptide delivery strategies and systems: In Vitro permeability and In Vivo oral absorption of salmon calcitonin (sCT)
11. Utility of pharmacodynamic measures for assessing the oral bioavailability of peptides. 1. Administration of recombinant salmon calcitonin in rats
12. Inhibition of HIV-1 replication by a Tat RNA-binding domain peptide analog
13. Translational effects of peptide antagonists of Tat protein of human immunodeficiency virus type 1
14. Influence of the microporous substratum and hydrodynamics on resistances to drug transport in cell culture systems: Calculation of intrinsic transport parameters
15. Interactions of a nonpeptidic drug, valacyclovir, with the human intestinal peptide transporter (hPEPT1) expressed in a mammalian cell line
16. +-dependent multivitamin transporter: Cloning, functional expression, gene structure, and chromosomal localization
17. Molecular mechanism of the intestinal biotin transport process
18. +-dependent multivitamin transporter
19. Cellular uptake of the tat protein from human immunodeficiency virus
20. Endocytosis and targeting of exogenous HIV-1 Tat protein
21. A novel integrin specificity exemplified by binding of the alpha v beta 5 integrin to the basic domain of the HIV Tat protein and vitronectin
22. Identification of an Arg-Gly-Asp (RGD) cell adhesion site in human immunodeficiency virus type 1 transactivation protein, tat
23. Identification of a novel cell attachment domain in the HIV-1 Tat protein and its 90-kDa cell surface binding protein
24. Human intestinal cell line Caco-2: A useful model for studying the cellular and molecular regulation of biotin uptake
25. Characterization of a sodium-dependent vitamin transporter mediating the uptake of pantothenate, biotin and lipoate in human placental choriocarcinoma cells
26. + gradient-dependent transport for biotin in human intestinal brush-border membrane vesicles
27. Biotin transport in basolateral membrane vesicles of human intestine
28. Transport of a large neutral amino acid (phenylalanine) in a human intestinal epithelial cell line: Caco- 2
29. Increased cellular uptake of the human immunodeficiency virus- 1 Tat protein after modification with biotin
30. Biotin uptake by human colonic epithelial NCM460 cells: A carrier-mediated process with pantothenic acid
31. Biotin transport through the blood brain barrier